• Exchange: -
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Agenix Ltd

AGXN:AU

Ticker Delisted

Snapshot for Agenix Ltd (AGXN)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for AGXN

No chart data available.
  • AGXN:AU
  • 1M
  • 1Y
0.0000
Interactive AGXN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AGXN

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AGXN

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for AGXN

Agenix Ltd. is a biotechnology company. The Company produces a monoclonal antibody diagnostic for live blood clots, and holds the rights in China to develop hepatitis B therapies.

Nicholas Weston "Nick"Chairman/CEOGary TaylorCFO/Secretary
Michael Gerometta "Mike"Chief Science Officer
More Company Profile & Key Executives for AGXN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • AGXN News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil